The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Programme Committee

  • Academia: Axel Glasmacher (CDDF Board)
  • Industry representatives : Claudia Hey (Merck Healthcare KGaA), Elisabeth Piault-Louis (Genentech), Marloes Van Bruggen (Roche)
  • Patient Advocates: Francesco De Lorenzo (ECPC, Italy)
  • Regulatory Authorities: Ralf Herold (EMA), Belinda King-Kallimanis (FDA)
  • HTA bodies: Margarida Oliveira (INFARMED), Giovanni Tafuri (EUnetHTA)